| Juan C Pallares, MD | |
|
Corner Route N12 And N7, Fort Defiance, AZ 86504 | |
| (928) 729-8000 | |
| Not Available |
| Full Name | Juan C Pallares |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | Corner Route N12 And N7, Fort Defiance, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578544987 | NPI | - | NPPES |
| 110390504 | Medicaid | TX | |
| 110390505 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | F8602 (Texas) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | ME87312 (Florida) | Secondary |
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20040315000385 |
News Archive
A team of researchers at University of California San Diego School of Medicine and Moores Cancer Center used CRISPR technology to identify key regulators of aggressive chronic myeloid leukemia, a type of cancer that remains difficult to treat and is marked by frequent relapse.
A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute's Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology.
Researchers in the United States have conducted a study showing that anti-sense agents called peptide-conjugated morpholino oligomers (PPMOs) have the ability to specifically and potently suppress the growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
A new large-scale genetic study found that low body mass index is likely not a causal risk factor for Alzheimer's disease, as earlier research had suggested, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
More than a quarter of over 70s with type 2 diabetes could benefit simply from improving communication and education in the clinic, new research has revealed. A study led by the University of Exeter Medical School and published in The Lancet found that 27 percent achieved better glycaemic control through individualised care alone.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan C Pallares, MD Po Box 649, Fort Defiance, AZ 86504-0649 Ph: (928) 729-8000 | Juan C Pallares, MD Corner Route N12 And N7, Fort Defiance, AZ 86504 Ph: (928) 729-8000 |
News Archive
A team of researchers at University of California San Diego School of Medicine and Moores Cancer Center used CRISPR technology to identify key regulators of aggressive chronic myeloid leukemia, a type of cancer that remains difficult to treat and is marked by frequent relapse.
A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute's Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology.
Researchers in the United States have conducted a study showing that anti-sense agents called peptide-conjugated morpholino oligomers (PPMOs) have the ability to specifically and potently suppress the growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
A new large-scale genetic study found that low body mass index is likely not a causal risk factor for Alzheimer's disease, as earlier research had suggested, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
More than a quarter of over 70s with type 2 diabetes could benefit simply from improving communication and education in the clinic, new research has revealed. A study led by the University of Exeter Medical School and published in The Lancet found that 27 percent achieved better glycaemic control through individualised care alone.
› Verified 3 days ago